Please try another search
For the three months ended 31 March 2016, Vivoline Medical AB revenues increased 87% to SEK1.2M. Net loss decreased 44% to SEK3.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Depreciation/Amortization decrease of 80% to SEK157K (expense), Personnel Costs decrease of 32% to SEK1.2M (expense).
Period Ending: | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 |
---|---|---|---|---|
Total Revenue | 1.21 | 1.1 | 0.89 | 0.92 |
Gross Profit | -2.4 | -3.73 | -2.48 | -3.78 |
Operating Income | -3.78 | -5.96 | -4.83 | -6.13 |
Net Income | -3.8 | -5.97 | -4.83 | -6.13 |
Period Ending: | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 |
---|---|---|---|---|
Total Assets | 23.6 | 28.56 | 8.64 | 13.37 |
Total Liabilities | 2.93 | 4.09 | 3.84 | 3.75 |
Total Equity | 20.67 | 24.47 | 4.8 | 9.62 |
Period Ending: | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -4.57 | -20.52 | -14.16 | -9.82 |
Cash From Investing Activities | -0.12 | -0.8 | -0.73 | -0.76 |
Cash From Financing Activities | -0.02 | 25.56 | 0 | 0 |
Net Change in Cash | -4.71 | 4.24 | -14.89 | -10.58 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review